Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Feb 10;18(1):38-46.
doi: 10.2119/molmed.2011.00339.

Extracellular superoxide dismutase overexpression can reverse the course of hypoxia-induced pulmonary hypertension

Affiliations

Extracellular superoxide dismutase overexpression can reverse the course of hypoxia-induced pulmonary hypertension

Mohamed N Ahmed et al. Mol Med. .

Abstract

Hypoxia leads to free radical production, which has a pivotal role in the pathophysiology of pulmonary hypertension (PH). We hypothesized that treatment with extracellular superoxide dismutase (EC-SOD) could ameliorate the development of PH induced by hypoxia. In vitro studies using pulmonary microvascular endothelial cells showed that cells transfected with EC-SOD had significantly less accumulation of xanthine oxidase and reactive oxygen species than nontransfected cells after hypoxia exposure for 24 h. To study the prophylactic role of EC-SOD, adult male wild-type (WT) and transgenic (TG) mice, with lung-specific overexpression of human EC-SOD (hEC-SOD), were exposed to fraction of inspired oxygen (FiO(2)) 10% for 10 d. After exposure, right ventricular systolic pressure (RVSP), right ventricular mass (RV/S + LV), pulmonary vascular wall thickness (PVWT) and pulmonary artery contraction/relaxation were assessed. TG mice were protected against PH compared with WT mice with significantly lower RVSP (23.9 ± 1.24 versus 47.2 ± 3.4), RV/S + LV (0.287 ± 0.015 versus 0.335 ± 0.022) and vascular remodeling, indicated by PVWT (14.324 ± 1.107 versus 18.885 ± 1.529). Functional studies using pulmonary arteries isolated from mice indicated that EC-SOD prevents hypoxia-mediated attenuation of nitric oxide-induced relaxation. Therapeutic potential was assessed by exposing WT mice to FiO(2) 10% for 10 d. Half of the group was transfected with plasmid containing cDNA encoding human EC-SOD. The remaining animals were transfected with empty vector. Both groups were exposed to FiO(2) 10% for a further 10 d. Transfected mice had significantly reduced RVSP (18.97 ± 1.12 versus 41.3 ± 1.5), RV/S + LV (0.293 ± 0.012 versus 0.372 ± 0.014) and PVWT (12.51 ± 0.72 versus 18.98 ± 1.24). On the basis of these findings, we concluded that overexpression of EC-SOD prevents the development of PH and ameliorates established PH.

PubMed Disclaimer

Figures

Figure 1
Figure 1
HPMECs nontransfected (N) and transfected (T) with EC-SOD after exposure to hypoxia for 24 h compared with a cell line incubated with FiO2 21% for 24 h. (A) Western blot for hEC-SOD protein and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) as an internal control. (B) XO concentration. (C) Intracellular reactive species and hydrogen peroxide measuring using DCF fluorescence over time. *Transfected cell line versus nontransfected cell line, P < 0.05. —◆—, RA; —■—, hypoxic nontransfected; —▲—, hypoxic transfected.
Figure 2
Figure 2
Evaluation of ROS concentration after exposure to hypoxia (FiO2 10% × 10 d) in WT and TG adult mice compared with normoxic groups. (A) XO concentration. (B) Total ROS concentration. Data are the mean of six animals per group ± SEM. *TG hypoxic versus WT hypoxic group, P < 0.05.
Figure 3
Figure 3
Evaluation of PH and cardiac hypertrophy after exposure to hypoxia (FiO2 10% × 10 d) in WT and TG adult mice compared with normoxic groups. (A) RV/S + LV ratio. (B) RVSP. (C) Images of BV stained for α-SMA and measurement showing the method of measurement of wall thickness. (D) Wall thickness of medium-sized pulmonary arteries assessed by immunostaining for anti–α-SMA. Data are the mean of six animals per each group ± SEM. *TG hypoxic versus WT hypoxic group, P < 0.05.
Figure 4
Figure 4
White blood cell counts and PMNs after exposure to hypoxia (FiO2 10% × 10 d) in WT and TG adult mice compared with normoxic groups. Data are the mean of six animals per group ± SEM. *TG hypoxic versus WT hypoxic group, P < 0.05. BAL, bronchoalveolar lavage; formula image, BAL, WBCs count × 1,000; formula image, BAL, PMNs count × 1,000.
Figure 5
Figure 5
Pulmonary artery function studies were performed on ~180 μm pulmonary arteries isolated from adult WT and TG animals exposed to hypoxia of FiO2 10% for 10 d compared with normoxic groups. (A) Contraction (grams) induced by PE (1–100 nmol/L = PE−9 to PE−7). (B) Relaxation (grams) induced by Ach (10 nmol/L to 10 μmol/L = Ach−9 to Ach−5). (C) Contraction induced by 5-HT (10 nmol/L to 10 μmol/L = 5-HT−8 to 5-HT−5). (D) Relaxation induced by spermine NONOate (NO, 1 nmol/L to 10 μmol/L, NO−9 to NO−5). Data are expressed as mean of four animals per each group. RA, room air; —◆—, WT RA; —■—, TG RA; —▲—, WT hypoxia; —×—TG hypoxia.
Figure 6
Figure 6
RV/S + LV ratio after exposure to hypoxia (FiO2 10% × 20 d) in both WT adult mice groups transfected with plasmid and EC-SOD or plasmid only (after 10 d of the exposure), compared with WT normoxic groups that were treated the same way. (A) Western blot for hEC-SOD protein. (B) RV/S + LV ratio. (C) RVSP. (D) Wall thickness of medium-sized pulmonary arteries assessed by immunostaining for anti–α-SMA. Data are the mean of six animals per group ± SEM. *Hypoxic transfected with plasmid + hEC-SOD versus hypoxic transfected with plasmid alone, P < 0.05.

References

    1. Stenmark KR, Fagan KA, Frid MG. Hypoxia-induced pulmonary vascular remodeling: cellular and molecular mechanisms. Circ Res. 2006;99:675–91. - PubMed
    1. Land RD. Neonatal chronic lung disease in the post-surfactant era. Biol Neonate. 2005;88:181–91. - PubMed
    1. Henderson-Smart DJ, et al. Prenatal predictors of chronic lung disease in very preterm infants. Arch Dis Child Fetal Neonatal Ed. 2006;91:40–5. - PMC - PubMed
    1. Tuder RM, Yun JH, Bhunia A, Fijalkowska I. Hypoxia and chronic lung disease. J Mol Med. 2007;12:1317–24. - PubMed
    1. Lai YL, Wu HD, Chen CF. Antioxidants attenuate chronic hypoxic pulmonary hypertension. J Cardiovasc Pharmacol. 1998;32:714–20. - PubMed

Publication types